R0 surgical resection of giant dedifferentiated retroperitoneal liposarcomas in the COVID era with and without nephrectomy: A case report
Francesca Pegoraro(Federico II University Hospital), Michele Santangelo(University of Naples Federico II), Luigi Insabato(Federico II University Hospital), Akbar Jamshidi(Federico II University Hospital), Vincenzo d’Alessandro, Nicola Carlomagno(Federico II University Hospital), Rossella Accarino(Federico II University Hospital), Mario Giuliano(Regione Campania), Domenico Santangelo(Vita-Salute San Raffaele University), Luigi Camera(Federico II University Hospital), Alfonso Santangelo(Vita-Salute San Raffaele University), Ciro Gabriele Mainolfi(Federico II University Hospital), L Pelosio(Federico II University Hospital), Massimo Imbriaco(University of Naples Federico II)
Cited by 2
Related Papers
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
|Journal of Clinical Oncology|2007|413
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
|Cancer Treatment Reviews|2018|282
Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2013|273
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
|Critical Reviews in Oncology/Hematology|2018|268